Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

CERESOLI, G. L ; ZUCALI, P. A ; SOTO-PARRA, H ; DE VINCENZO, F ; BRUZZONE, A ; LORENZI, E ; GIANONCELLI, L ; ERCOLI, B ; GIORDANO, L ; SANTORO, A ; MENCOBONI, M ; BOTTA, M ; GROSSI, F ; CORTINOVIS, D ; ZILEMBO, N ; RIPA, C ; TISEO, M ; FAVARETTO, A. G

British journal of cancer, 2013-08, Vol.109 (3), p.552-558 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível